Key Takeaways Aflac shows steady growth from strong U.S. and Japan sales and high policy persistency rates.AFL benefits from new product launches, partnerships and AI use to boost efficiency and sales.AFL faces pressure from declining cash flow and a higher valuation than industry averages.Aflac Incorporated (AFL) is strategically positioned to grow, driven by strong product demand and high policy persistency across its key markets, stronger underwriting discipline and effective cost management.Aflac — with ...

Aflac Incorporated, a life and health insurer through its subsidiaries in Japan and the U.S., has announced that Aflac Re Bermuda Ltd. (Aflac Re) has agreed with Japan Post Insurance Co., Ltd. to reinsure a block of whole life annuities through coinsurance, effective 31st March 2026.This marks Aflac Re’s first reinsurance transaction with an external party. Japan Post Insurance will continue to service and administer the policies.Max Brodén, Senior Executive Vice President, Chief Financial Officer of Aflac ...

Aflac Re Bermuda Ltd. Announces Reinsurance Transaction with Japan Post Insurance Company Accessibility StatementSkip Navigation FORWARD-LOOKING INFORMATIONThe Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially ...

Aflac Incorporated (NYSE:AFL) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. KBW Sees Mixed Fundamentals in Life Insurance, Starts Aflac (AFL) at Market Perform On March 26, Keefe Bruyette & Woods re-initiated coverage of Aflac Incorporated (NYSE:AFL) with a Market Perform rating and a $113 price target. The analyst said the life insurance sector shows a mixed fundamental picture. Companies have reduced liability tail risk and improved free cash flow conversion, while ...

Core Insights - Aflac Incorporated (AFL) has launched a hybrid worksite benefit that combines term life insurance with long-term care (LTC) coverage, addressing the rising costs of care and enhancing consumer financial security [1][5]. Product Features - The new rider allows for an extended LTC benefit period and restores the full face value of the life insurance policy even after LTC funds have been utilized, along with an optional inflation protection feature [2][9]. - It includes a fund that grows annually to increase the overall value of the LTC benefit, offering flexible payment options such as lump-sum or periodic payments [3]. - Coverage is portable, enabling policyholders to retain benefits after leaving their employer, and full LTC benefits can be accessed regardless of the care setting [4][9]. Market Context - The introduction of this product is timely, as the cost of LTC is rising, creating challenges for an aging U.S. population and increasing the demand for comprehensive life and LTC planning [5]. - Aflac's new offering is expected to enhance customer satisfaction, attract new policyholders, and improve retention among existing customers, potentially leading to increased premium income [6]. Financial Performance - In 2025, Aflac's U.S. unit generated net earned premiums of $6 billion, reflecting a year-over-year growth of 2.9%, with total new sales increasing by 3% during the same period [7]. - Net earned premiums are projected to grow at the lower end of the 3-6% range in 2026 for the U.S. business [7]. Share Price and Industry Comparison - Aflac's shares have declined by 2.8% over the past year, compared to a 4.6% decline in the industry [8].

Core Insights - Aflac has introduced a new long-term care rider as part of its Group Life Term to 120 product, aimed at providing financial protection against rising long-term care costs for aging Americans [1][5] - The product is designed to meet the growing need for life insurance and long-term care planning as the U.S. population ages, with projections indicating that 1 in 6 Americans will be over 60 by 2030 [2][3] Product Features - The new long-term care rider offers flexibility, allowing insured individuals to choose between home-based care, facility-based care, or care from family and friends, thus catering to personal preferences [3][4] - Key benefits include optional extensions of the LTC benefit period, restoration of life insurance amounts after LTC funding, inflation protection, and various payment options [6][4] Market Context - The introduction of this product aligns with the demographic shift known as the "Silver Tsunami," where baby boomers are reaching retirement age, increasing the demand for long-term care solutions [2][3] - Aflac's initiative is positioned to help employers attract and retain talent by offering benefits that provide security and choice to employees [4][5]

Core Insights - Aflac has been recognized as a World's Most Ethical Company for 20 consecutive years, making it the only insurance company to achieve this distinction since the award's inception in 2007 [1][2][4] Company Recognition - Aflac's Chairman and CEO, Dan Amos, expressed that this recognition serves as a consistent approval of the ethical actions of the company's employees and leaders, highlighting the correlation between ethical conduct and better company performance [2][3] - In 2026, a total of 138 companies were recognized as honorees, spanning 17 countries and 40 industries, with only six organizations being recognized for 20 times [4] Community Commitment - Aflac has a long-standing commitment to community support, notably contributing nearly $200 million to the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta since 1995 [2] Ethical Standards - The assessment for the World's Most Ethical Companies is based on Ethisphere's proprietary Ethics Quotient®, which evaluates companies on over 240 documented proof points related to ethics and compliance practices [5]

Core Viewpoint - Aflac's recent earnings report showed mixed results, with adjusted earnings per share missing estimates while revenues declined year over year, raising questions about the company's future performance leading up to the next earnings release [2][3]. Financial Performance - Aflac reported Q4 2025 adjusted EPS of $1.57, missing the Zacks Consensus Estimate by 8.2%, but showing a year-over-year improvement of 0.6% [3]. - Adjusted revenues for the quarter totaled $4.9 billion, a decline of 9.9% year over year, although it beat the consensus mark by 8.7% [3]. - Adjusted net investment income decreased by 4.4% year over year to $920 million [5]. - Total acquisition and operating expenses increased by 3.5% year over year to $1.4 billion [5]. Segment Performance - Aflac Japan's adjusted revenues fell 3.6% year over year to $2.3 billion, missing the consensus estimate [6]. - In Aflac U.S., adjusted revenues grew 3.3% year over year to $1.73 billion but also missed the consensus estimate [7]. Full-Year Update - For the full year 2025, adjusted EPS improved by 3.5% year over year to $7.46, while total revenues fell by 9.3% to $17.2 billion [9]. Financial Position - As of December 31, 2025, Aflac had total investments and cash of $103.8 billion, a decrease of 1.3% from the previous year [10]. - Adjusted debt increased by 7.1% to $7.7 billion, with total shareholders' equity rising by 13% to $29.5 billion [11]. Capital Deployment - Aflac repurchased 7.2 million shares for $800 million in Q4 2025 and announced a quarterly dividend increase of 5.2% to 61 cents per share [13]. 2026 Outlook - Aflac anticipates a benefit ratio of 60-63% for the Japan unit and 48-52% for the U.S. unit in 2026 [14]. - The company expects a year-over-year decline of 1-2% in underlying earned premiums for the Japan unit, while the U.S. unit is projected to grow at the lower end of the 3-6% range [14]. Market Sentiment - Since the earnings release, there has been an upward trend in estimates for Aflac, although the stock currently holds a Zacks Rank 4 (Sell), indicating expectations of below-average returns in the near term [16][18].

Company Overview - Aflac Incorporated (AFL) is an insurance company providing supplemental financial-protection products primarily in the U.S. and Japan, with a market capitalization of $58.06 billion [1] Stock Performance - Aflac's shares reached a 52-week high of $119.32 on February 5, but are currently down 5.7% from that peak, reflecting a slow but steady growth profile [2] - Over the past three months, Aflac's stock has gained 3%, outperforming the Dow Jones Industrial Average, which is up 1.9% during the same period [2] - In the past 52 weeks, Aflac's stock has increased by 4.5%, while the Dow Jones index has risen by 14.6% [3] - Year-to-date, Aflac's stock has increased by 2%, compared to the Dow's gain of 1.4% [3] - The stock has been trading above its 50-day moving average since late January and above its 200-day moving average since late October [3] Financial Results - Aflac reported a 9.9% year-over-year decline in quarterly revenue for fiscal Q4 2025, totaling $4.87 billion, which was higher than analysts' expectations, resulting in a 3.4% intraday stock gain on February 5 [4] Strategic Focus - For 2026, Aflac aims to focus on third-sector products in the Aflac Japan segment to attract younger customers, while in the U.S. segment, the focus is on profitable growth through strong underwriting discipline and improved agent productivity [5] Market Comparison - Compared to MetLife, which has dropped 10.1% over the past 52 weeks and 7.1% year-to-date, Aflac has shown clear outperformance [6] - Aflac's stock has a consensus rating of "Hold" from 15 analysts, with a mean price target of $112.38, indicating flat performance from current levels, while the highest price target of $130 suggests a potential upside of 15.6% [6]

Core Insights - Aflac Incorporated (NYSE:AFL) is recognized as one of the 14 Best Affordable Dividend Stocks to buy according to analysts [1] - Wells Fargo analyst Elyse Greenspan raised the price target for Aflac to $118 from $109 while maintaining an Equal Weight rating, reflecting a shift in valuation approach and updated EPS estimates for 2027 and 2028 [2] Financial Performance - In Q4 2025, Aflac reported net earnings of $2.64 per diluted share and adjusted earnings of $1.57 per diluted share, indicating strong financial performance [3] - Aflac Japan experienced a sales increase of 15.7% in Q4 and 16% for the full year, driven by the success of the Miraito cancer insurance product, which saw a 35.6% sales increase [3] - Aflac U.S. generated nearly $1.6 billion in new sales in 2025, with over one-third of that amount coming in Q4 [4] Strategic Initiatives - The company emphasized a focus on profitable growth, careful underwriting, and disciplined expense management, with a premium persistency rate of 79.2% [4] - Aflac's board approved a 5.2% dividend increase for Q1 2026, and in 2025, the company returned significant capital to shareholders, including $3.5 billion for share repurchases and $1.2 billion in dividends [4] Business Overview - Aflac Incorporated provides supplemental health and life insurance in the U.S. and Japan, offering financial protection to policyholders [5]